BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, February 11th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and February earnings reports.

NEW YORK, Feb. 9 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. , a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today the signing of its first research, distribution, sales and marketing agreement for its Percutaneous Hepatic Perfusion System ). The agreement grants ...

Pest and termite control company Rollins Inc. said Tuesday its board of directors has raised its quarterly dividend by 29 percent.

Medical products company Becton Dickinson and Co. said Monday it expanding a recall for catheter devices because a manufacturing problem could cause potentially fatal embolisms or blood leakage.

A Goldman Sachs analyst has lowered price targets for two medical device makers and added a third sell-rated company to its "Americas Conviction" list after forecasting slow growth for implantable cardioverter defibrillators.

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, February 4th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and February earnings reports.

SurModics Inc. filed Quarterly Report for the period ended 2009-12-31. Surmodics Inc.

St. Jude Medical, Inc. announced European CE Mark approval and first implants of its Fortify and Fortify ST implantable cardioverter defibrillators and Unify cardiac resynchronization therapy defibrillator .

Baxter International Inc. reported strong performance for the fourth quarter of 2009, and provided its financial outlook for the first quarter and full-year 2010 .

Drug and medical device maker Baxter International Inc. spent over a million dollars lobbying on the health care reform effort and related bills in the fourth quarter.

Feb. 5 -- Stanley Bergman, chief executive officer of Henry Schein Inc., talks with Bloomberg's Pimm Fox about the performance of the company's business units, including its animal-health joint venture, and the outlook for Henry Schein's Hong Kong-based dental business.

David Smith's termination from PSS World Medical Inc. came with a hefty $2.72 million severance and other benefits, according to a new regulatory filing with the U.S. Securities and Exchange Commission .

St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration clearance of the Swift-Lock anchor, a new product designed to help physicians efficiently secure neurostimulation leads utilized in spinal cord stimulation therapy for the management of chronic pain.

ResMed Inc says it is well positioned for the future, after the sleep management company booked a 42 per cent rise in net income for the first half of this financial year.

ZOLL Medical Corporation , a manufacturer of medical devices and related software solutions, announced today that SAMU Brasilia , based in the capital city of Brazil and one of the largest EMS services in the country, has equipped its ambulances with the AutoPulse Non-Invasive Cardiac Support Pump.

PSS World Medical Inc. surprised investors Feb. 3 with the announcement that David Smith was stepping down as CEO, stating only that he "terminated his employment with the company by mutual agreement." The board immediately promoted Chief Operating Officer Gary A. Corless to CEO.

Main Category: Cardiovascular / Cardiology Also Included In: Clinical Trials / Drug Trials St.

Analyst Report ) reported third quarter fiscal 2010 earnings per share of 71 cents, missing the Zacks Consensus Estimate of 72 cents.

Zimmer Dental, a provider of dental oral rehabilitation products and a subsidiary of Zimmer Holdings, has announced expansion of a portfolio of Zimmer Plastic Temporary Abutments for the Tapered Screw-Vent and Screw-Vent Implant Systems.

Hologic Inc., which makes mammogram systems and other women's health diagnostic tools, said Monday its fiscal first-quarter profit fell 32 percent, hurt by charges and continued capital spending restraint by hospitals.